Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on CN116041345B. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN116041345B reveals copper-catalyzed synthesis of hydantoin skeletons. Offers cost reduction and supply chain reliability for pharmaceutical intermediate manufacturing.